Publication: 3430

Publication: 3430

Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: JAMA vol 325 (13) 1277-1285

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 10

Parents:: 3228
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:: Pfizer
Grants:: U10CA180821, U10CA180882, U10CA180794, UG1CA233163, UG1CA233253, UG1CA233290, UG1CA233320, UG1CA233337, UG1CA233339, UG1CA189954, U10CA180863 (CCTG); UG1CA233196, U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);

Corr. Author:
Authors:: Jeffrey A. Meyerhardt Qian Shi Charles S. Fuchs Jeffrey Meyer Donna Niedzwiecki Tyler Zemla Priya Kumthekar Katherine A. Guthrie Felix Couture Philip Kuebler Johanna C. Bendell Pankaj Kumar Dequincy Lewis Benjamin Tan Monica Bertagnolli Axel Grothey Howard S. Hochster Richard M. Goldberg Alan Venook Charles Blanke Eileen M. O'Reilly Anthony F. Shields

Networks:: CA824, HEARTLAND, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, OR013, SCOR

Study: Alliance-A151939
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-80702
Phases:: N/A, 3

Keywords:: Research, Research, Original Investigation